Bone morphogenetic protein receptor 2 mutations in adults and children with idiopathic pulmonary arterial hypertension - Association with thyroid disease

被引：16

作者：

Roberts, KE

Barst, RJ

McElroy, JJ

Widlitz, A

Chada, K

Knowles, JA

Morse, JH

机构：

[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA

[2] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA

[3] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA

[4] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ USA

来源：

CHEST | 2005年 / 128卷 / 06期

关键词：

D O I：

10.1378/chest.128.6_suppl.618S

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

引用

页码：618S / 618S

页数：1

共 50 条

[31] Bone Morphogenetic Protein Receptor 2 Expression Is Reduced in Blood Across Pulmonary Arterial Hypertension Subtypes but Does Not Reflect Disease Severity
Sweatt, A.
Wells, R. E.
Purington, N.
Hedlin, H.
Sudheendra, D.
Hsi, A.
Zamanian, R. T.
Spiekerkoetter, E. F.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[32] Prevalence and clinical features of bone morphogenetic protein receptor type 2 mutation in Korean idiopathic pulmonary arterial hypertension patients: The PILGRIM explorative cohort
Jang, Albert Youngwoo
Kim, Bo-Gyeong
Kwon, Sunkoo
Seo, Jiyoung
Kim, Hyung Kwan
Chang, Hyuk-Jae
Chang, Sung-A
Cho, Goo-Yeong
Rhee, Sang Jae
Jung, Hae Ok
Kim, Kyung-Hee
Seo, Hye Sun
Kim, Kye Hun
Shin, Jinho
Lee, Jun Soo
Kim, Minsu
Lee, Young Jae
Chung, Wook-Jin
PLOS ONE, 2020, 15 (09):
[33] Role of Bone Morphogenetic Protein Receptors in the Development of Pulmonary Arterial Hypertension
Morrell, Nicholas W.
MEMBRANE RECEPTORS, CHANNELS AND TRANSPORTERS IN PULMONARY CIRCULATION, 2010, 661 : 251 - 264
[34] Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival - Implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension
Teichert-Kuliszewska, K
Kutryk, MJB
Kuliszewski, MA
Karoubi, G
Courtman, DW
Zucco, L
Granton, J
Stewart, DJ
CIRCULATION RESEARCH, 2006, 98 (02) : 209 - 217
[35] Right Ventricular Adaptation And Treatment Response In Pulmonary Arterial Hypertension Patients With A Bone Morphogenetic Protein Receptor 2 Mutation
Van Der Bruggen, C. E. E.
Trip, P.
Van De Veerdonk, M.
Rain, S.
Handoko, M. L.
Westerhof, N.
Van Der Velden, J.
Noordegraaf, A. Vonk
Bogaard, H. J.
Goumans, M.
De Man, F.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
[36] Mutations of bone morphogenetic protein receptor 2 (BMPR2) are not found in patients with pulmonary hypertension and connective tissue disorders
Tew, MB
Arnett, FC
Reveille, JD
Tan, FK
ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S130 - S130
[37] Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertension
Rudarakanchana, N
Flanagan, JA
Chen, HL
Upton, PD
Machado, R
Patel, D
Trembath, RC
Morrell, NW
HUMAN MOLECULAR GENETICS, 2002, 11 (13) : 1517 - 1525
[38] Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation
Tian, Wen
Jiang, Xinguo
Sung, Yon K.
Shuffle, Eric
Wu, Ting-Hsuan
Kao, Peter N.
Tu, Allen B.
Dorfmueller, Peter
Cao, Aiqin
Wang, Lingli
Peng, Gongyong
Kim, Yesl
Zhang, Patrick
Chappell, James
Pasupneti, Shravani
Dahms, Petra
Maguire, Peter
Chaib, Hassan
Zamanian, Roham
Peters-Golden, Marc
Snyder, Michael P.
Voelkel, Norbert F.
Humbert, Marc
Rabinovitch, Marlene
Nicolls, Mark R.
CIRCULATION, 2019, 140 (17) : 1409 - 1425
[39] Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection
Li, Wei
Quigley, Kate
BIOCHEMICAL SOCIETY TRANSACTIONS, 2024, 52 (03) : 1515 - 1528
[40] Bone morphogenetic protein signalling in pulmonary arterial hypertension: revisiting the BMPRII connection
Li, Wei
Quigley, Kate
BIOCHEMICAL SOCIETY TRANSACTIONS, 2024, : 1515 - 1528

← 1 2 3 4 5 →